Momenta Pharmaceuticals is a biotechnology company with a validated, innovative scientific platform. We focus on discovering and developing novel therapeutics to treat rare immune-mediated diseases, while advancing our late stage biosimilar portfolio.
Momenta is a part of the Janssen Pharmaceutical Companies of Johnson & Johnson.